Literature DB >> 9667602

Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia.

R B Wilson1, D R Lynch, K H Fischbeck.   

Abstract

Friedreich's ataxia (FRDA) is caused by point mutations or trinucleotide repeat expansions in both alleles of the gene encoding frataxin. Studies of frataxin homologues in lower eukaryotes suggest that mitochondrial iron accumulation may underlie the pathophysiology of FRDA. To evaluate the possible role of iron-chelation therapy for FRDA, we measured serum iron and ferritin concentrations in 10 FRDA patients. The measurements were within normal limits, suggesting that iron-chelation therapy for FRDA may be problematic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667602     DOI: 10.1002/ana.410440121

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

Review 2.  The yeast connection to Friedreich ataxia.

Authors:  S A Knight; R Kim; D Pain; A Dancis
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

3.  New developments and controversies in iron metabolism and iron chelation therapy.

Authors:  Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2016-03-26

4.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

5.  Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.

Authors:  A O Hausse; Y Aggoun; D Bonnet; D Sidi; A Munnich; A Rötig; P Rustin
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 6.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

Review 7.  Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors:  Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-12-26

8.  Frataxin activates mitochondrial energy conversion and oxidative phosphorylation.

Authors:  M Ristow; M F Pfister; A J Yee; M Schubert; L Michael; C Y Zhang; K Ueki; M D Michael; B B Lowell; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 9.  Autosomal recessive cerebellar ataxias.

Authors:  Francesc Palau; Carmen Espinós
Journal:  Orphanet J Rare Dis       Date:  2006-11-17       Impact factor: 4.123

Review 10.  Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Authors:  George J Kontoghiorghes; Christina N Kontoghiorghe
Journal:  Cells       Date:  2020-06-12       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.